Literature DB >> 24452495

Correction of hemostatic abnormalities and portal pressure variations in patients with cirrhosis.

Edoardo G Giannini1, R Todd Stravitz, Stephen H Caldwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24452495     DOI： 10.1002/hep.27029

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

Review 1.  Algorithms for managing coagulation disorders in liver disease.

Authors:  R Todd Stravitz
Journal:  Hepatol Int       Date:  2018-07-31       Impact factor: 6.047

Review 2.  Coagulopathy in liver disease: Lack of an assessment tool.

Authors:  Annabel Blasi
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

Review 3.  Changing Concepts of Cirrhotic Coagulopathy.

Authors:  Armando Tripodi; Massimo Primignani; Pier M Mannucci; Stephen H Caldwell
Journal:  Am J Gastroenterol       Date:  2016-11-01       Impact factor: 10.864

4.  Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review.

Authors:  Christina R Evans; Adam Cuker; Mark Crowther; Allyson M Pishko
Journal:  Res Pract Thromb Haemost       Date:  2022-05-22

Review 5.  Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia.

Authors:  Domenico Alvaro; Nicola Caporaso; Edoardo Giovanni Giannini; Angelo Iacobellis; Mariacristina Morelli; Pierluigi Toniutto; Francesco Violi
Journal:  Eur J Clin Invest       Date:  2021-02-26       Impact factor: 4.686

Review 6.  Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease.

Authors:  Zvonimir Ostojic; Ana Ostojic; Josko Bulum; Anna Mrzljak
Journal:  World J Cardiol       Date:  2021-11-26

Review 7.  The Edge of Unknown: Postoperative Critical Care in Liver Transplantation.

Authors:  Fuat H Saner; Dieter P Hoyer; Matthias Hartmann; Knut M Nowak; Dmitri Bezinover
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.